home.aspx
 
EVENTS

Annual Psychopharmacology Update
ANNUAL PSYCHOPHARMACOLOGY UPDATE
December 04-05, 2020
Annual Psychopharmacology Update features the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more.

Pharmaceutical Drug Pricing Strategies Summit
PHARMACEUTICAL DRUG PRICING STRATEGIES SUMMIT
December 09-10, 2020
The Pharmaceutical Drug Pricing Strategies Summit is designed to bring senior pricing and reimbursement leaders to discuss the future of federal and state pricing requirements, transparency regulations, and strategic drug pricing models.

ADEVIA HEALTH

SHARESHARESHARE
ADEVIA HEALTH LIMITED is a Hospital and Health Care company located in London, United Kingdom. Adevia Health is a many years active recruitment companies in the health sector. The company specializes in the placement of health and nursing in the USA. Adevia Health works with selected hospitals, including a year-long and trusting business relationship is maintained.
SHARESHARESHARE

RELATED NEWS


Two months back, AstraZeneca and Merck made a strong case at the American Society of Clinical Oncology ASCO annual meeting that Lynparza should be the first PARP inhibitor approved to treat prostate cancer, with data showing the drug significantly delayed disease progression when added to Johnson and Johnsons Zytiga. Now the Lynparza partners have a fresh set of data to back up their case, and this time its for use of the drug as a solo therapy. Merck and AstraZeneca said they have seen positive...

READ MORE

Patheon N.V. ("Patheon" or the "company") (NYSE:PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltd., which it will integrate into the Patheon network....

READ MORE

Breast cancer is a rare disease in men, making it tough for drugmakers to conduct clinical trials. But Pfizer came up with a solution. The pharma giant scored a new nod Thursday for big-seller Ibrance in males, based largely on real-world evidence. Along the way, regulators studied data from electronic health records and post-marketing reports from the IQVIA Insurance database, the Flatiron Health Breast Cancer database and Pfizer's own global safety database. The result? An FDA green light ...
FIERCEPHARMA
READ MORE

Omron, a ubiquitous name when it comes to blood pressure measurement, is about to release the first smartwatch that can measure blood pressure directly from the wrist. The Omron HeartGuide sports a band that doubles as a blood pressure cuff, inflating when requested through the touchscreen of the watch. The watch can be programmed to take blood pressure readings even while sleeping, a particularly useful feature as sleep-time readings can be the most accurate when assessing a patient’s bas...

READ MORE

The Home Office is set to appoint a new national recovery champion to support recovering drug addicts to turn their lives around by making sure they have access to adequate housing, employment, and mental health services, under plans announced today to cut illicit drug use and boost the number of people who get clean. And health services will be expected to carry out additional checks to track the progress of those in recovery at 12 months, as well as after six, to ensure they remain drug-fre...

READ MORE

Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund (CDF) in England has shown that the fund was not good value for patients and society and may have resulted in patients suffering unnecessarily from toxic side effects of the drugs....

READ MORE

EVENTS

Annual Psychopharmacology Update
ANNUAL PSYCHOPHARMACOLOGY UPDATE
December 04-05, 2020
Annual Psychopharmacology Update features the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more.

Pharmaceutical Drug Pricing Strategies Summit
PHARMACEUTICAL DRUG PRICING STRATEGIES SUMMIT
December 09-10, 2020
The Pharmaceutical Drug Pricing Strategies Summit is designed to bring senior pricing and reimbursement leaders to discuss the future of federal and state pricing requirements, transparency regulations, and strategic drug pricing models.